Last reviewed · How we verify
GELOX
At a glance
| Generic name | GELOX |
|---|---|
| Also known as | gemcitabine, oxaliplatin, asparaginase, pegaspargase |
| Sponsor | Sun Yat-sen University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL (PHASE2)
- Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |